In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of ...
J.P. Morgan analyst Chris Schott maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $115.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback